Orexigen Therapeutics Inc logo

OREXQ - Orexigen Therapeutics Inc Share Price

$0.005 0.0  37.7%

Last Trade - 31/05/19

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £58.0m
Position in Universe th / 6371
Bullish
Bearish
Unlock OREXQ Revenue
Momentum
Relative Strength (%)
1m +31.8%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2011 2012 2013 2014 2015 2016 2017E 2018E CAGR / Avg
4.40 3.43 3.43 55.5 24.5 33.7 84.7 156.5 +50.3%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2017, Orexigen Therapeutics, Inc. revenues increased from $19.8M to $61.4M. Net loss totaled $120.4M vs. income of $85K. Revenues reflect Net product sales increase from $8.2M to $61M. Net loss reflects General and administrative -others increase of 79% to $127.2M (expense), Change in fair value of financial instru decrease from $17.7M (income) to $22.7M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

OREXQ Revenue Unlock OREXQ Revenue

Net Income

OREXQ Net Income Unlock OREXQ Revenue

Normalised EPS

OREXQ Normalised EPS Unlock OREXQ Revenue

PE Ratio Range

OREXQ PE Ratio Range Unlock OREXQ Revenue

Dividend Yield Range

OREXQ Dividend Yield Range Unlock OREXQ Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
OREXQ EPS Forecasts Unlock OREXQ Revenue
Profile Summary

Orexigen Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the treatment of obesity. The Company's product, Contrave, is approved in the United States by the United States Food and Drug Administration as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of 30 kilograms per square meter or greater (obese) or 27 kilograms per square meter or greater (overweight) in the presence of a weight-related comorbid condition. Contrave is a combination of generic drug components, each of which has received regulatory approval for other indications and has been commercialized in the United States and in a range of member countries of the European Union. Contrave regulates appetite and energy expenditure through central nervous system (CNS) activity. Contrave is a fixed dose combination of bupropion hydrochloride (HCl) extended release (ER) and naltrexone HCl ER.

Directors
Last Annual December 31st, 2016
Last Interim September 30th, 2017
Incorporated September 12, 2002
Public Since April 26, 2007
No. of Shareholders: n/a
No. of Employees: 132
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange OTC Markets Group
Shares in Issue 18,887,033
Free Float (0.0%)
Eligible for
ISAs
SIPPs
OREXQ Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for OREXQ
Upcoming Events for OREXQ
Frequently Asked Questions for Orexigen Therapeutics Inc
What is the Orexigen Therapeutics Inc share price?

As of 31/05/19, shares in Orexigen Therapeutics Inc are trading at $0.005, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Orexigen Therapeutics Inc share price performed this year?

Shares in Orexigen Therapeutics Inc are currently trading at $0.005 and the price has moved by -96.21% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Orexigen Therapeutics Inc price has moved by -96.51% over the past year.

What are the analyst and broker recommendations for Orexigen Therapeutics Inc?

Of the analysts with advisory recommendations for Orexigen Therapeutics Inc, there are there are currently 0 "buy" , 0 "hold" and 1 "sell" recommendations. The overall consensus recommendation for Orexigen Therapeutics Inc is Strong Sell. You can view the full broker recommendation list by unlocking its StockReport.

When will Orexigen Therapeutics Inc next release its financial results?

Orexigen Therapeutics Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2018-09-30
What is the Orexigen Therapeutics Inc dividend yield?

Orexigen Therapeutics Inc does not currently pay a dividend.

Does Orexigen Therapeutics Inc pay a dividend?

Orexigen Therapeutics Inc does not currently pay a dividend.

When does Orexigen Therapeutics Inc next pay dividends?

Orexigen Therapeutics Inc does not currently pay a dividend.

How do I buy Orexigen Therapeutics Inc shares?

To buy shares in Orexigen Therapeutics Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Orexigen Therapeutics Inc?

Shares in Orexigen Therapeutics Inc are currently trading at $0.005, giving the company a market capitalisation of £n/a.

Where are Orexigen Therapeutics Inc shares listed? Where are Orexigen Therapeutics Inc shares listed?

Here are the trading details for Orexigen Therapeutics Inc:

Country of listing: United States
Exchange: OTC
Ticker Symbol: OREXQ
What kind of share is Orexigen Therapeutics Inc?

We were not able to load our ranking data for Orexigen Therapeutics Inc

Is there a Orexigen Therapeutics Inc share price forecast 2020?

We were not able to load any forecast data for Orexigen Therapeutics Inc.

How can I tell whether the Orexigen Therapeutics Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Orexigen Therapeutics Inc. Over the past six months, the relative strength of its shares against the market has been -23.44%. At the current price of $0.005, shares in Orexigen Therapeutics Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Orexigen Therapeutics Inc PE Ratio?

We were not able to find PE ratio data for Orexigen Therapeutics Inc.

Who are the key directors of Orexigen Therapeutics Inc?

We were unable to find the directors for Orexigen Therapeutics Inc.

Who are the major shareholders of Orexigen Therapeutics Inc?

Here are the top five shareholders of Orexigen Therapeutics Inc based on the size of their shareholding:

Similar to OREXQ
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.